LENZ Therapeutics gets FDA nod for presbyopia eye drop

13 hours ago 1

LENZ Therapeutics (NASDAQ:LENZ) said that the U.S. FDA approved its eye drop, Vizz (aceclidine ophthalmic solution) 1.44%, for the treatment of presbyopia in adults.
The company stated that it expects the commercial product to be widely accessible by mid-Q4 2025, with

Recommended For You